Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Focal reduction in left ventricular 123I-metaiodobenzylguanidine uptake and impairment in systolic function in patients with Anderson-Fabry disease.

Spinelli L, Imbriaco M, Giugliano G, Nappi C, Gaudieri V, Riccio E, Pisani A, Trimarco B, Cuocolo A.

J Nucl Cardiol. 2019 May 13. doi: 10.1007/s12350-019-01734-8. [Epub ahead of print]

PMID:
31087266
2.

Optical Coherence Tomography Angiography Findings in Fabry Disease.

Cennamo G, Di Maio LG, Montorio D, Tranfa F, Russo C, Pontillo G, Cocozza S, Esposito R, Di Risi T, Imbriaco M, Spinelli L, Riccio E, Pisani A.

J Clin Med. 2019 Apr 17;8(4). pii: E528. doi: 10.3390/jcm8040528.

3.

Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial.

Perico N, Ruggenenti P, Perna A, Caroli A, Trillini M, Sironi S, Pisani A, Riccio E, Imbriaco M, Dugo M, Morana G, Granata A, Figuera M, Gaspari F, Carrara F, Rubis N, Villa A, Gamba S, Prandini S, Cortinovis M, Remuzzi A, Remuzzi G; ALADIN 2 Study Group.

PLoS Med. 2019 Apr 5;16(4):e1002777. doi: 10.1371/journal.pmed.1002777. eCollection 2019 Apr.

4.

Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson-Fabry disease: AFFINITY study group.

Imbriaco M, Nappi C, Ponsiglione A, Pisani A, Dell'Aversana S, Nicolai E, Spinelli L, Aiello M, Diomiaiuti CT, Riccio E, Esposito R, Galderisi M, Losi M, Greiser A, Chow K, Cuocolo A.

Eur Heart J Cardiovasc Imaging. 2019 Mar 16. pii: jez039. doi: 10.1093/ehjci/jez039. [Epub ahead of print]

PMID:
30879055
5.

Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial.

Ruggenenti P, Trillini M, P Barlovic D, Cortinovis M, Pisani A, Parvanova A, Iliev IP, Ruggiero B, Rota S, Aparicio MC, Perna A, Peraro F, Diadei O, Gaspari F, Carrara F, Stucchi N, Martinetti D, Janez A, Gregoric N, Riccio E, Bossi AC, Trevisan R, Manunta P, Battaglia G, David S, Aucella F, Belviso A, Satta A, Remuzzi G; VALID Study Organization.

Diabetes Obes Metab. 2019 May;21(5):1177-1190. doi: 10.1111/dom.13639. Epub 2019 Feb 22.

PMID:
30793466
6.

Data on the assessment of LV mechanics by speckle tracking echocardiography in ADPKD patients.

Spinelli L, Pisani A, Giugliano G, Trimarco B, Riccio E, Visciano B, Remuzzi G, Ruggenenti P.

Data Brief. 2018 Nov 14;21:2075-2081. doi: 10.1016/j.dib.2018.11.041. eCollection 2018 Dec.

7.

Left ventricular dysfunction in ADPKD and effects of octreotide-LAR: A cross-sectional and longitudinal substudy of the ALADIN trial.

Spinelli L, Pisani A, Giugliano G, Trimarco B, Riccio E, Visciano B, Remuzzi G, Ruggenenti P; ALADIN-Cardiovascular Study Group.

Int J Cardiol. 2019 Jan 15;275:145-151. doi: 10.1016/j.ijcard.2018.10.063. Epub 2018 Oct 22.

PMID:
30509370
8.

Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?

Duro G, Zizzo C, Cammarata G, Burlina A, Burlina A, Polo G, Scalia S, Oliveri R, Sciarrino S, Francofonte D, Alessandro R, Pisani A, Palladino G, Napoletano R, Tenuta M, Masarone D, Limongelli G, Riccio E, Frustaci A, Chimenti C, Ferri C, Pieruzzi F, Pieroni M, Spada M, Castana C, Caserta M, Monte I, Rodolico MS, Feriozzi S, Battaglia Y, Amico L, Losi MA, Autore C, Lombardi M, Zoccali C, Testa A, Postorino M, Mignani R, Zachara E, Giordano A, Colomba P.

Int J Mol Sci. 2018 Nov 23;19(12). pii: E3726. doi: 10.3390/ijms19123726.

9.

Glomerular Hyperfiltration: An Early Marker of Nephropathy in Fabry Disease.

Riccio E, Sabbatini M, Bruzzese D, Annicchiarico Petruzzelli L, Pellegrino A, Spinelli L, Esposito R, Imbriaco M, Feriozzi S, Pisani A; on behalf of AFFIINITY Group.

Nephron. 2019;141(1):10-17. doi: 10.1159/000493469. Epub 2018 Nov 22.

PMID:
30466100
10.

Metformin in autosomal dominant polycystic kidney disease: experimental hypothesis or clinical fact?

Pisani A, Riccio E, Bruzzese D, Sabbatini M.

BMC Nephrol. 2018 Oct 22;19(1):282. doi: 10.1186/s12882-018-1090-3.

11.

Absence of infratentorial lesions in Fabry disease contributes to differential diagnosis with multiple sclerosis.

Ugga L, Cocozza S, Pontillo G, Russo C, Brescia Morra V, Lanzillo R, Riccio E, Pisani A, Brunetti A.

Brain Behav. 2018 Nov;8(11):e01121. doi: 10.1002/brb3.1121. Epub 2018 Oct 2.

12.

Multiple sclerosis and fabry Disease, two sides of the coin? The case of an Italian family.

Russo C, Riccio E, Pontillo G, Cocozza S, Tedeschi E, Centonze D, Pisani A.

Mult Scler Relat Disord. 2018 Nov;26:164-167. doi: 10.1016/j.msard.2018.09.019. Epub 2018 Sep 19.

PMID:
30268036
13.

Reduced Intracranial Volume in Fabry Disease: Evidence of Abnormal Neurodevelopment?

Pontillo G, Cocozza S, Brunetti A, Brescia Morra V, Riccio E, Russo C, Saccà F, Tedeschi E, Pisani A, Quarantelli M.

Front Neurol. 2018 Aug 17;9:672. doi: 10.3389/fneur.2018.00672. eCollection 2018.

14.

Prominent longitudinal strain reduction of left ventricular basal segments in treatment-naïve Anderson-Fabry disease patients.

Esposito R, Galderisi M, Santoro C, Imbriaco M, Riccio E, Maria Pellegrino A, Sorrentino R, Lembo M, Citro R, Angela Losi M, Spinelli L, Trimarco B, Pisani A.

Eur Heart J Cardiovasc Imaging. 2019 Apr 1;20(4):438-445. doi: 10.1093/ehjci/jey108.

PMID:
30085001
15.

Striatonigral involvement in Fabry Disease: A quantitative and volumetric Magnetic Resonance Imaging study.

Russo C, Pontillo G, Pisani A, Saccà F, Riccio E, Macera A, Rusconi G, Stanzione A, Borrelli P, Brescia Morra V, Tedeschi E, Brunetti A, Cocozza S, Palma G.

Parkinsonism Relat Disord. 2018 Dec;57:27-32. doi: 10.1016/j.parkreldis.2018.07.011. Epub 2018 Jul 21.

PMID:
30054181
16.

A pilot study of circulating microRNAs as potential biomarkers of Fabry disease.

Cammarata G, Scalia S, Colomba P, Zizzo C, Pisani A, Riccio E, Montalbano M, Alessandro R, Giordano A, Duro G.

Oncotarget. 2018 Jun 8;9(44):27333-27345. doi: 10.18632/oncotarget.25542. eCollection 2018 Jun 8.

17.

Early Cardiac Involvement Affects Left Ventricular Longitudinal Function in Females Carrying α-Galactosidase A Mutation: Role of Hybrid Positron Emission Tomography and Magnetic Resonance Imaging and Speckle-Tracking Echocardiography.

Spinelli L, Imbriaco M, Nappi C, Nicolai E, Giugliano G, Ponsiglione A, Diomiaiuti TC, Riccio E, Duro G, Pisani A, Trimarco B, Cuocolo A.

Circ Cardiovasc Imaging. 2018 Apr;11(4):e007019. doi: 10.1161/CIRCIMAGING.117.007019.

PMID:
29626078
18.

Default mode network modifications in Fabry disease: A resting-state fMRI study with structural correlations.

Cocozza S, Pontillo G, Quarantelli M, Saccà F, Riccio E, Costabile T, Olivo G, Brescia Morra V, Pisani A, Brunetti A, Tedeschi E; AFFINITY study group.

Hum Brain Mapp. 2018 Apr;39(4):1755-1764. doi: 10.1002/hbm.23949. Epub 2018 Jan 9.

PMID:
29315984
19.

Genetic variants associated with Fabry disease progression despite enzyme replacement therapy.

Scionti F, Di Martino MT, Sestito S, Nicoletti A, Falvo F, Roppa K, Arbitrio M, Guzzi PH, Agapito G, Pisani A, Riccio E, Concolino D, Pensabene L.

Oncotarget. 2017 Nov 18;8(64):107558-107564. doi: 10.18632/oncotarget.22505. eCollection 2017 Dec 8.

20.

Current Tissue Molecular Markers in Colorectal Cancer: A Literature Review.

Peluso G, Incollingo P, Calogero A, Tammaro V, Rupealta N, Chiacchio G, Sandoval Sotelo ML, Minieri G, Pisani A, Riccio E, Sabbatini M, Bracale UM, Dodaro CA, Carlomagno N.

Biomed Res Int. 2017;2017:2605628. doi: 10.1155/2017/2605628. Epub 2017 Oct 29. Review.

Supplemental Content

Loading ...
Support Center